ciprofloxacin has been researched along with polymyxin b(1) in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 6 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, S; Dou, X; Shan, A; Song, J; Wang, J; Wang, Z; Yang, Y; Yang, Z | 1 |
| Campagne, JM; Gerber, C; Gualtieri, M; Marcia de Figueiredo, R; Midrier, C; Pantel, L; Racine, E; Sarciaux, M; Serri, M; Villain-Guillot, P | 1 |
| Gou, S; Ni, J; Xie, J; Yao, J; Zhang, F; Zhong, C; Zhu, N; Zhu, Y | 1 |
| Alezra, V; Deng, X; Fang, Y; Hu, C; Jin, Y; Wan, Y; Xie, S; Zeng, L; Zeng, Z; Zhu, J | 1 |
| Ba, Z; Chang, L; Gou, S; Li, B; Liu, H; Ni, J; Ouyang, X; Zhang, J; Zhang, T; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y | 1 |
| Choi, W; Efremov, RG; Konshina, AG; Lohan, S; Mandal, D; Maslennikov, I; Parang, K; Tiwari, RK | 1 |
| Lohan, S; Mohammed, EHM; Parang, K; Tiwari, RK | 1 |
| Aggarwal, B; Bajaj, A; Gupta, S; Gupta, SK; Jain, D; Kumar, S; Kumar, Y; Mehta, D; Pal, G; Pal, S; Rajput, K; Ramu, VS; Rana, K; Rani, P; Saini, V | 1 |
8 other study(ies) available for ciprofloxacin and polymyxin b(1)
| Article | Year |
|---|---|
Combating Drug-Resistant Fungi with Novel Imperfectly Amphipathic Palindromic Peptides.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Candida albicans; Cytoplasm; Drug Resistance, Fungal; HEK293 Cells; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Intracellular Membranes; Inverted Repeat Sequences; Mice; Models, Molecular; Peptides; Protein Conformation; RAW 264.7 Cells | 2018 |
Total Synthesis and Structure-Activity Relationships Study of Odilorhabdins, a New Class of Peptides Showing Potent Antibacterial Activity.
Topics: Animals; Anti-Bacterial Agents; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Molecular Structure; Peptide Fragments; Protein Biosynthesis; Respiratory Tract Infections; Ribosome Subunits, Small; Structure-Activity Relationship; Xenorhabdus | 2018 |
Ultra-short lipopeptides against gram-positive bacteria while alleviating antimicrobial resistance.
Topics: Animals; Anti-Bacterial Agents; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Gram-Positive Bacteria; Lipopeptides; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2021 |
Polymyxin B-inspired non-hemolytic tyrocidine A analogues with significantly enhanced activity against gram-negative bacteria: How cationicity impacts cell specificity and antibacterial mechanism.
Topics: Anti-Bacterial Agents; Cell Line; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Structure; Polymyxin B; Staphylococcus aureus; Structure-Activity Relationship; Tyrocidine | 2021 |
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pneumonia, Bacterial; Pore Forming Cytotoxic Proteins; Structure-Activity Relationship; Wasp Venoms | 2021 |
Small Amphiphilic Peptides: Activity Against a Broad Range of Drug-Resistant Bacteria and Structural Insight into Membranolytic Properties.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteria; Cell Membrane; Cell Survival; Drug Design; Gram-Negative Bacteria; Gram-Positive Bacteria; HEK293 Cells; Hemolysis; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Dynamics Simulation; Peptides | 2022 |
Amphiphilic cyclic peptide [W
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Meropenem; Microbial Sensitivity Tests; Peptides, Cyclic; Pseudomonas aeruginosa | 2022 |
Targeting Vancomycin-Resistant
Topics: Anti-Bacterial Agents; Cholic Acid; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Operon; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2022 |